Heraeus will now bring the full potential of the technology to market maturity for various fields of application. "We are currently working at full speed to introduce AGXX particles into materials and products that are susceptible to colonization by germs. AGXX can thus also make a contribution to contain COVID-19," says Martin Danz, Head of Business Development at Heraeus Precious Metals.
AGXX particles have an excellent antimicrobial effect, which has already been successfully tested against more than 130 microorganisms, including Sars-CoV-2 viruses. In addition, AGXX offers many other advantages compared to conventional antimicrobial solutions: The AGXX particles contain neither pharmaceuticals nor toxic organics. The effect is also not based on the release of metal ions. The innovative AGXX technology generates free oxygen radicals in situ on the surfaces, which are mainly responsible for the antimicrobial effect. Therefore, AGXX does not lose its effectiveness during a longer time. Subsequent costs due to maintenance and renewal can be significantly reduced.